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Abstract
Background: Syphilis causes up to 1,500,000 congenital syphilis cases annually. These could be prevented if all
pregnant women were screened, and those with syphilis treated with a single dose of penicillin before 28 weeks
gestation. In recent years, rapid point-of-care tests have allowed greater access to syphilis screening, especially in
rural or remote areas, but the lack of quality assurance of rapid testing has been a concern. We determined the
feasibility of using dried blood spots (DBS) as specimens for quality assurance of syphilis serological assays.
Methods: We developed DBS extraction protocols for use with Treponema pallidum particle agglutination assay
(TPPA), Treponema pallidum haemagglutination assay (TPHA) and an enzyme immunoassay (EIA) and compared the
results with those using matching plasma samples from the same patient.
Results: Since DBS samples showed poor performance with TPHA and EIA (TPHA sensitivity was 50.5% (95%
confidence interval: 39.9–61.2%) and EIA specificity was 50.4% (95% CI: 43.7–57.1%), only the DBS TPPA was used in
the final evaluation. DBS TPPA showed an sensitivity of 95.5% (95% CI: 91.3–98.0%) and a specificity of 99.0% (95%
CI: 98.1–99.5%) compared to TPPA using plasma samples as a reference.
Conclusion: DBS samples can be recommended for use with TPPA, and may be of value for external quality
assurance of point-of-care syphilis testing.
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Background
It is estimated that the burden of congenital syphilis is
large, with 1.5 million cases per year worldwide [1]. These
could be prevented if all pregnant women were screened
and treated with a single dose of benzathine penicillin be-
fore 28 weeks gestation [2]. Syphilis testing is usually done
using laboratory based assays such as Treponema pallidum
haemagglutination assay (TPHA), Treponema pallidum
particle agglutination assay (TPPA), rapid plasma reagin
(RPR), or enzyme Immunoassay (EIA). These tests need to
be used with serum or plasma samples and require a cen-
trifuge, shaker, and refrigeration for the reagents. They are
therefore less suitable than point-of-care tests (POCT) for
use in rural or remote locations. POCT screening tests for
syphilis that are sensitive and specific in detecting trepo-
nemal antibodies are now available [3]. The main
advantages of POCTs are that they are easy to use, can be
stored at room temperature, and can be used with whole
blood, collected with a finger prick. The Global Report on
Preterm Birth and Stillbirth and modelling studies have
identified syphilis POCTs testing and treatment as an ur-
gent priority for reducing perinatal morbidity and mortality
[4-6]. Many countries have therefore started to scale up
the use of POCTs in prenatal screening programmes for
syphilis, but the lack of suitable methods for external qual-
ity assurance (EQA) is a serious concern.
Most QA methods have been developed to monitor
the quality of tests performed in the laboratory, and are
not designed for monitoring POCT usage by healthcare
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workers at remote locations [7]. Dried Blood Spots
(DBS) have been suggested to be a suitable EQA meth-
odology for HIV POCTs, since they are easily collected,
require minimal training and can be sent at ambient
temperature for retesting at a centralised laboratory [8].
DBS samples have been used in prevalence studies for
syphilis serology, but without prior validation of the
methodology [9-11]. DBS samples have been evaluated
with TPPA [12], TPHA [13], and an in-house EIA which
is not commercially available [14]. The TPHA used in
the study by Backhouse et al. is no longer commercially
available. The fourteen year old TPPA protocol used by
Coates et al. did not include a control for biologically re-
active samples, and the final testing concentration of
DBS eluate was more diluted than with plasma, poten-
tially leading to reduced sensitivity for samples with low
antibody titres [12]. The objectives of this study were to
develop and validate DBS protocols for use with com-
mercially available syphilis diagnostic assays, and to de-
termine their performance in syphilis serological assays
using plasma samples as a reference.
Methods
Research setting
The Kisesa open cohort is a well-established on-going
community-based study covering six villages in northern
Tanzania. The cohort study conducts regular demographic
surveillance on HIV prevalence and incidence [15]. Sexual
behaviour data and HIV status are collected by surveys for
which all adults aged 15 years or older are eligible to par-
ticipate. Study participants that opted for voluntary coun-
selling and testing (VCT) were offered HIV and syphilis
POCT (SD Bioline, USA) performed by trained and
experienced technicians. If the VCT participant was trepo-
nemal antibody positive by POCT, free medical treatment
was provided according to the Tanzanian government
recommendations, and all those positive for HIV were re-
ferred to Tanzanian care-and treatment centres. The study
was approved by the Medical Research Coordinating
Committee of the National Institute for Medical Research
in Tanzania (NIMR) and the ethical committee of the
London School of Hygiene and Tropical Medicine.
Procedures
For the community based HIV study, DBS samples
(Proteinsaver 903 filter paper, Whatman, GE healthcare,
USA) were collected by finger prick, air dried at ambient
temperature for at least 3 hours and stored with
desiccants in individual ziplock bags. DBS samples were
transported at ambient temperature and upon arrival at
the laboratory stored at −20°C. After participants
donated a DBS sample, they were invited to opt in for
VCT. Whole blood samples were collected from
consenting participants who opted in for VCT by trained
clinicians and transported to the NIMR laboratory in
Mwanza. EDTA blood samples were bar-coded in the
field to ensure anonymous testing. Within 24 hours, the
blood samples were centrifuged and plasma was stored
in 3 aliquots (1 mL each) at −20°C. From all subjects
participating in the serosurvey who opted for VCT,
1,645 samples were randomly selected for this study.
All syphilis serology assays were performed according
to manufacturer’s directions. The positive and negative
controls supplied with the kits were used with every run.
The technicians were blinded to other test results and
TPHA and TPPA results were read by two trained la-
boratory technicians. All tests were performed in at the
NIMR laboratory, which participates in the WHO EQA
programs for TPPA and Rapid plasma Reagin (RPR)
tests. An active syphilis case is defined as RPR positive,
confirmed by a treponemal test. The results were
entered using the laboratory information management
system.
The protocol development and evaluation was divided
into two phases. In the first phase, we determined the
feasibility of using DBS with TPHA, TPPA and EIA
using 464 samples. During DBS protocol development,
care was taken to ensure an equivalent DBS sample in-
put was used for each serological method, compared to
plasma. In the second phase, the serological tests that
work best with DBS were selected and validated with
1,181 samples (Figure 1). Plasma samples were used as
the reference standard. The RPR test was performed on
plasma samples that gave discrepant results between
DBS and plasma samples to determine if any active
syphilis cases might have been missed. Active syphilis in-
fection was defined as a positive TPPA and RPR test.
Samples were prospectively collected from July through
September 2010 and were tested until March 2011. Dur-
ing phase 1, the preliminary evaluation of different syph-
ilis serological methods with DBS samples, TPPA, TPHA
and EIA were all performed from the same DBS eluate
as only one DBS spot was available. As a reference
method, TPPA, TPHA and EIA were performed on
matching plasma samples in parallel. To ensure blinded
reading in the laboratory, plasma samples were tested
before DBS samples. Additionally, the three tests on
DBS were performed separately from each other, to
maintain blindness to other test results.
TPPA
A total of 1,645 plasma aliquots were brought to room
temperature and 25 μl were used to test for treponemal
antibodies by TPPA (Fujirebio, Tokyo, Japan), according
to manufacturer’s protocols, by laboratory technicians
who routinely perform TPPA on plasma samples.
For DBS TPPA testing, the protocol was adjusted as
follows. A 6 mm disk was manually punched and eluted
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in 100 μl Phosphate buffered Saline (PBS) with 0.05%
Tween80 in a clean 96 flat wells plate, shaken for 2 -
minutes and eluted overnight at 4°C. Upon the next day,
the plate was shaken 2 minutes and brought to room
temperature. 25 μl sample dilution buffer was added to
the first column of a clean 96 U-shaped plate, 25 μl DBS
eluate was added and mixed thoroughly. 25 μl of the
mixture was transferred to a second column and 25 μl
sensitized particles were added to column one, 25 μl
unsensitized particles to column two. Plates were
covered and incubated for at least two hours at room
temperature on a vibration free surface, before result in-
terpretation. Discordant results between the two
technicians were recorded as indeterminate. This proto-
col allows TPPA and HIV serological tests to be
performed from one DBS spot.
TPHA
Plasma aliquots were brought to room temperature and
25 μl were used to test for treponemal antibodies by TPHA
(Lab21 syphilis TPHA, Lab21 healthcare, Kentford, UK).
TPHA plasma tests were performed according to
manufacturer’s protocols by trained laboratory technicians.
For DBS TPHA testing, the following protocol was
developed; 25 μl of DBS eluate (obtained as described
above) was added to 25 μl sample diluent, mixed and
divided over two wells (25 μl each). 75 μl test or control
cells were added and incubated for 1 hour. For both
TPHA and TPPA protocols, the final DBS sample elu-
tion volume was kept comparable with plasma sample
volume. Discordant results between the two technicians
were recorded as indeterminate.
EIA
Plasma aliquots were brought to room temperature and
50 μl were used to test for treponemal antibodies by En-
zyme Immuno Assay (EIA) (Lab21 Syphilis Total Anti-
body EIA, Lab21 healthcare, Kentford, UK). EIA plasma
tests were performed according to manufacturer’s
protocols by trained laboratory technicians.
A DBS EIA protocol was developed in collaboration
with the developer of the assay. 40 μl DBS eluate was
added and incubated for two hours at 37°C. Plates were
washed five times using an automated washer, 50 μl con-
jugate was added, shaken and incubated for 30 minutes
at 37°C, washed five times, 50 μl substrate was added
and incubated for 30 minutes at room temperature while
kept in the dark. 50 μl stop solution was added and the
wells were read as Optical Density (OD) 450/620 nm
using an automated reader (DTX 800, Beckman Coulter,
USA) with cut-off limits calculated according to the in-
struction manual. The results were then entered directly
into the laboratory information management system.
RPR
Quantitative RPR (BD Macro-vue RPR, Beckton
Dickinson, Sparks MD, USA) was performed according
to manufacturer’s protocols using plasma samples by
trained laboratory technicians.
Data analysis
The sensitivity, specificity and confidence intervals were
calculated according to standard methods. The agree-
ment between various methods was tabulated. Microsoft
Excel (Microsoft, USA) and the statistical software Stata
11 (StataCorp LP, Texas, USA) were used for analysis of
the results.
Results
Phase 1: Preliminary evaluation of different syphilis
serological methods with DBS samples
During the first phase of the project, protocols for DBS
samples were developed for TPPA, (DBS TPPA) TPHA
(DBS TPHA) and EIA (DBS EIA). 464 DBS samples
were tested with TPPA, TPHA, and EIA. Table 1 shows
the sensitivity and specificity of all three syphilis serology
tests using DBS samples compared to plasma samples.
1645
matching plasma 
and DBS samples
Phase 1
464 matching 
samples
TPPA-464 samples tested
EIA-282 samples tested
TPHA-445 samples tested
Phase 2
1181 matching 
samples
TPPA
RPR–1171 plasma samples 
tested
–1181 samples 
Figure 1 Study design diagram. The number of matching plasma
and DBS samples used for each phase of the study are given in the
boxes on the left and the number of matching DBS and plasma
samples tested for each of the assays are given in the boxes on the
right. RPR has been performed on plasma, not on DBS.
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The DBS EIA was discontinued before the end of phase
1 because of the many false positive results (specificity
50.4%). The TPHA was also excluded from further
testing because of low sensitivity (50.6%).
To improve sensitivity of DBS TPPA, technicians were
trained to use a lower cut-off for interpretation of the DBS
TPPA test results, based on the agglutination patterns
seen in phase 1. Reading was adjusted by altering the ag-
glutination positive and negative thresholds applied for
DBS samples because of the higher background compared
to plasma samples (Figure 2).
Phase 2: Evaluation of DBS samples in comparison to
matching plasma samples
For the final evaluation of DBS TPPA, 1,181 matching
DBS and plasma samples were included. The average age
was 31.9 years (range 15–84) and 760 participants were fe-
male (64%). For 8 persons, no data on gender or age was
recorded and for another 3 persons no data on gender
was available. Out of the 1,181 samples, 179 (15.2%)
plasma samples tested positive by TPPA (Table 2). Exclud-
ing 34 indeterminate results, DBS TPPA showed a sensi-
tivity of 95.5% (95% CI: 91.3–98.0%) and a specificity of
99.0% (95% CI: 98.1–99.5%) compared to TPPA plasma as
the reference method. The DBS TPPA reading
adjustments incorporated in phase 2 resulted in a 10.1%
increase in sensitivity without compromising specificity.
An overall agreement of 98.7% between the two readers
was found. No non-specific reactivity (positive with
unsensitized particles) with DBS samples was detected. Of
the 34 indeterminate results for DBS TPPA, 30 (88.3%)
were negative and 4 (11.7%) were positive for TPPA using
plasma samples. Out of the 34 indeterminate results, 15
samples were deemed indeterminate because of discord-
ant readings by two technicians and 16 samples were
called indeterminate by both technicians. Of the 179
TPPA positive plasma samples, 66 were RPR positive
(Table 3). DBS detected 66 out of 67 samples that were
plasma TPPA and RPR positive. The one discordant result
was DBS TPPA indeterminate. Unfortunately it was not
possible to retest the 10 false positive DBS samples since
insufficient sample eluate was available by the time plasma
and DBS results were compared. To obtain the titration of
the eight false negative DBS samples, matching plasma
samples were retested with quantitative TPPA and quanti-
tative RPR, as shown in Table 4. Four plasma samples
were negative when retested with TPPA, suggesting a bor-
derline sample or false positive reading when initially
tested.
Discussion
We developed and validated protocols for the use of
DBS samples with various syphilis serological assays.
DBS samples can be recommended for use with TPPA,
and may be of value for external quality assurance of
point-of-care syphilis testing. When finger-prick blood
has been obtained to perform syphilis POC testing, DBS
can be used to collect blood for EQA purposes directly
afterwards. Finger-prick blood spotted onto filter paper
can be stored and shipped at room temperature,
Table 1 Preliminary evaluation: performance of three syphilis serological assays using Dried Blood Spots compared to
plasma
Plasma as reference (using the same assay) Positive samples
detected
Negative samples
detected
Sensitivity (95% CI) * Specificity (95% CI) *
DBS TPPA† (n=463) 82/96 363/367 85.4% 98.9%
(76.7–91.8%) (97.2–99.7%)
DBS EIA (n=282) 53/56 114/226 94.6% 50.4%
(85.1–98.9%) (43.7–57.1%)
DBS TPHA‡ (n=445) 46/91 353/354 50.5% 99.7%
(39.9–61.2%) (98.4–100%)
n= samples.
* 95% confidence interval.
† 1 TPPA DBS indeterminate excluded.
‡ 19 TPHA indeterminate results excluded.
Figure 2 DBS TPPA test result of seven patients. Test outcome (− = negative, + − = indeterminate, and + = positive) was used in phase 2 of
this study.
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allowing the samples to be transported to a central la-
boratory where retesting can be done. The reduction in
required materials, no cold chain requirements and min-
imal training of personnel at clinic level, decreases costs
considerably in comparison to standard blood collection
by venepuncture [16]. Additionally, the stability of
human antibodies stored on DBS has been shown to be
resilient to ambient temperatures for months [17-19].
This potentially makes DBS a suitable sample for EQA
of POCTs in remote settings.
Unfortunately, we were not able to obtain acceptable
performance for the use of DBS samples with the Syph-
ilis Total Antibody EIA and Lab21 Syphilis TPHA. The
EIA false positive results were primarily caused by a high
background, possibly due to substances eluted from the
filter paper and whole blood that adhered non-
specifically to the wells. The TPHA false negative results
were most likely caused by a reduced sensitivity when
using DBS samples. DBS samples tested with TPPA gave
a sensitivity of 95.5% and specificity of 99.0% compared
to plasma samples.
Of the eight samples that were false negative by DBS
TPPA, four were negative when retested with quantita-
tive TPPA on plasma samples and four were false
negatives, of which two had relatively high TPPA titres
(1/320 and 1/640). We tested all plasma samples using
the RPR assay to determine if any of the false negative
samples were from women with active syphilis, defined
as being RPR and TPPA positive. Since only one false
negative DBS sample was positive for RPR, TPPA using
DBS samples showed excellent sensitivity for the detec-
tion of active syphilis
It should be noted the study took place in Tanzania.
Although tests were performed and stored according to
the manufacturer’s recommendations, potential environ-
mental effects by transporting and using the kits under
tropical conditions could not be completely ruled out.
Additionally, only one DBS spot was available per sam-
ple which restricted the ability to retest discordant test
results or develop appropriate procedures for indeter-
minate samples.
Because TPPA is an agglutination assay, experience in
reading results is essential and therefore training is ne-
cessary. 34 DBS samples (3%) were marked as indeter-
minate due to difficulty in interpreting the results or
because of discordant reading by two technicians. DBS
samples can potentially be used for quantitation with
TPPA, although it would require evaluation against titers
obtained with plasma samples. Because of the subjectiv-
ity, it is recommended that TPPA should be read by two
readers.
DBS TPPA has been used as a surveillance tool in a
few studies [9,11,12] that used a protocol developed by
Coates et al. [12]. The DBS TPPA protocol developed in
this study is an improvement to the protocol developed
by Coates et al. as we adjusted the elution so that the
sample input into the TPPA assays from DBS and
plasma are comparable. We also included unsensitized
particles in the procedure to control for biologically re-
active samples.
Conclusions
As prenatal screening for syphilis using POCTs becomes
widely implemented, an EQA method appropriate for
use with blood collected by a finger prick must be
developed to assure the proficiency of POC testing in
rural or remote areas. The objectives of this study were
to develop and validate DBS protocols for use with com-
mercially available syphilis diagnostic assays, and to
Table 2 Correlation between detection of Treponema
pallidum antibodies by plasma TPPA and DBS TPPA
(n=1147) TPPA plasma
Positive Negative Total
DBS TPPA Positive 169 10 179
Negative 8 960 968
Total 177 970 1147*
sensitivity of DBS against plasma 95.5% (95% CI: 91.3–98,0%).
specificity of DBS against plasma 99.0% (95% CI: 98.1–99.5%).
* excluding 34 indeterminate results.
Table 3 RPR titres of TPPA DBS positive samples
RPR titre N=179
Negative 113
1/1 13
1/2 19
1/4 13
1/8 7
1/16 4
1/32 6
1/64 1
>1/128 3
Table 4 Rapid Plasma Reagin (RPR) results on 8 plasma
samples with false negative DBS TPPA results
Sample DBS TPPA* RPR†
BBI99P N N N
BBI792 N N N
BBI6GG N N N
BBI5YI N N N
BBI8ZC N 1/80 N
BBI6LP N 1/160 N
BBI6K6 N 1/320 N
BBI6NZ N >1/640 1/64
N= negative.
* Quantitative TPPA.
† Quantitative RPR.
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determine their performance in syphilis serological assays
using plasma samples as a reference. Based on the high
sensitivity and specificity of DBS TPPA compared to
plasma TPPA, DBS can be recommended for use with
TPPA. Our study also showed the importance of training
laboratory technicians in performing and reading the DBS
TPPA, even when they are already trained in plasma TPPA.
We obtained a 10.1% increase in sensitivity when
technicians were more experienced in interpreting DBS
TPPA agglutinations.
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